RankingsPricing
  1. US-listed companies
  2. ABEONA THERAPEUTICS INC.
  3. Financials
  4. Total assets

ABEONA THERAPEUTICS INC.ABEO

Market cap
$248.11M
P/E ratio
SummaryFinancials
Period EndTotal assets (Million USD)YoY (%)
Dec 31, 2024109+70.20%
Dec 31, 202364-0.33%
Dec 31, 202264-19.31%
Dec 31, 202180-47.36%
Dec 31, 2020151-32.31%
Dec 31, 2019223+28.09%
Dec 31, 2018174-2.44%
Dec 31, 2017179+60.97%
Dec 31, 2016111+38.73%
Dec 31, 201580+382.78%
Dec 31, 201417+2605.06%
Dec 31, 20131-64.57%
Dec 31, 20122-54.29%
Dec 31, 20114

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)